MDS is a bone marrow failure disorder

- Featured News and Events -

- GET ANSWERS -

Mom has MDS and isn't telling ANYONE
Hello everyone - My situation is odd, at best. My 74-year old mother was ...
1 week, 2 days ago
12 wks pregnant with 1st child and diagnosed high risk MDS
Hi I'm searching for anyone who may of been in a similar situation that I now ...
1 week, 2 days ago
MDS Meds
I'm MDS RARS. Why is my Aranesp failing to help me? Anyone have experience ...
3 weeks, 5 days ago

- GET TREATMENT -

CENTERS OF EXCELLENCE
Would you like your treatment center to become part of the referral system for MDS patients and be designated as a Center of Excellence? To be recognized as a Center of Excellence, an institution must have:
  • An established university (or equivalent) program
  • Recognized morphologic expertise in MDS
  • Available cytogenetics and/or molecular genetics
  • Ongoing research, including Institutional Review Board-approved clinical trials
  • Documentation of peer-reviewed publications in the field
LEARN MORE
CLINICAL TRIALS
Clinical trials study new interventions (drugs or procedures) to evaluate their safety and effectiveness in humans. Trials follow a careful set of steps, allowing for the systematic gathering of information to answer questions and confirm hypotheses that were formed earlier, in either laboratory experiments or preliminary trials. If you are an MDS patient, you may wish to discuss a trial with your primary treating physician to see if you qualify as a candidate. LEARN MORE
 
RECENT NEWS
Results from Phase III Study of REVLIMID® (Lenalidomide) Demonstrating Improved Transfusion Independence in Patients with Rare Blood Cancer, Non-Del-5Q Myelodysplastic Syndromes (MDS), Presented at ASH
SAN FRANCISCO--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced results from an international phase III study of REVLIMID® (lenali LEARN MORE
VI. International Eurasian Congress of Hematology
CONGRESSINVITATION from the Hematology Specialists Association, Turkey:   Dear Colleagues, We are pleased to announce that VI. Internatio LEARN MORE
CONNECT WITH US
Review answers to commonly asked questions or get answers to your questions from an MDS expert